<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Publications</title>
  <link rel="stylesheet" href="style.css" />
</head>

<body>
  <!-- Hero image -->
  <div class="hero-image">
    <div class="hero-text">
      <h1>ðŸ“– Publications</h1>
    </div>
  </div>

  <!-- Navigation -->
  <header>
    <nav>
      <a href="index.html">About</a>
      <a href="team.html">Team</a>
      <a href="publications.html">Publications</a>
      <a href="contact.html">Get Involved</a>
    </nav>
  </header>

  <main>
    <!-- Introduction -->
    <section class="fellowship-card">
      <h2>Introduction</h2>
      <p>
        The Chin-Yee & Hsia Hematology Research Lab is dedicated to advancing the 
        understanding, diagnosis, and treatment of blood disorders through rigorous 
        clinical and translational research. Below is a selection of highlights 
        showcasing our impact, followed by comprehensive publication lists for 
        Dr. Benjamin Chin-Yee and Dr. Cyrus Hsia.
      </p>
    </section>

    <!-- Selected Highlights -->
    <section class="fellowship-card fellowship-card--with-media">
      <div class="fellowship-card__content">
        <h2>ðŸ”¬ Selected Highlights</h2>
        <ul>
          <li><strong>Cancer Labeling, Risk Perception, and Treatment Choices in Clonal Cytopenia of Undetermined Significance.</strong> <em>JAMA Network Open</em>. 2025;8(7):e2523733. (Chin-Yee B, Latham AJ, Varga S)</li>
          <li><strong>SGLT2i-associated erythrocytosis: Closing the evidence gap.</strong> <em>Blood Advances</em>. 2025;9(16):4321-4322. (Chin-Yee B; Hsia CC)</li>
          <li><strong>A Single-Center Retrospective Study of the Investigation of Monoclonal B-Cell Lymphocytosis (MBL) and Chronic Lymphocytic Leukemia (CLL) in Southwestern Ontario: Are We Over-Investigating?</strong> <em>Int J Lab Hematol</em>. 2025;47(5):891-897. (Hoxha O; Lad M; Hedley BD; Chin-Yee B; Hsia CC; et al.)</li>
          <li><strong>Eltrombopag versus intravenous immunoglobulin for first-line treatment of immune thrombocytopenia: a randomized trial.</strong> <em>Lancet Haematol</em>. 2020;7(9):e640-e648. (Hsia CC, co-investigator)</li>
          <li><strong>Erythrocytosis associated with sodiumâ€“glucose cotransporter 2 inhibitors: case series and literature review.</strong> <em>CMAJ</em>. 2020;192(7):E171-E175. (Chin-Yee B, first author)</li>
          <li><strong>Next-generation sequencing panels for hematologic malignancies: implementation and clinical impact.</strong> <em>Eur J Haematol</em>. 2019;103(6):599-606. (Chin-Yee B, first author)</li>
        </ul>
      </div>
    </section>

    <!-- Full Publications -->
    <section class="fellowship-card">
      <h2>ðŸ“š Full Publications</h2>

      <!-- Dr. Benjamin Chin-Yee -->
      <h3>Dr. Benjamin Chin-Yee</h3>
      <details>
        <summary>2025</summary>
        <ul>
          <li>Chin-Yee B; Latham AJ; Varga S. <em>JAMA Network Open</em>. 2025;8(7):e2523733.</li>
          <li>Chin-Yee B; Hsia CC. <em>Blood Advances</em>. 2025;9(16):4321-4322.</li>
          <li>Hoxha O; Lad M; Hedley BD; Chin-Yee B; Hsia CC; et al. <em>Int J Lab Hematol</em>. 2025;47(5):891-897.</li>
        </ul>
      </details>

      <details>
        <summary>2024</summary>
        <ul>
          <li>Chin-Yee B, et al. Communication and decision-making between laboratory and clinic in hematology practice. <em>Am J Hematol</em>. 2024.</li>
        </ul>
      </details>

      <details>
        <summary>2020</summary>
        <ul>
          <li>Chin-Yee B, et al. Erythrocytosis associated with sodiumâ€“glucose cotransporter 2 inhibitors: case series and literature review. <em>CMAJ</em>. 2020;192(7):E171-E175.</li>
        </ul>
      </details>

      <details>
        <summary>2019</summary>
        <ul>
          <li>Chin-Yee B, et al. Next-generation sequencing panels for hematologic malignancies: implementation and clinical impact. <em>Eur J Haematol</em>. 2019;103(6):599-606.</li>
        </ul>
      </details>

      <p><em>Other Contributions (2019â€“2025):</em> Publications and presentations on diagnostic test utilization, Choosing Wisely Hematology, and laboratoryâ€“clinic communication in patient care.</p>

      <!-- Dr. Cyrus Hsia -->
      <h3>Dr. Cyrus Hsia</h3>
      <details>
        <summary>2025</summary>
        <ul>
          <li>Chin-Yee B; Hsia CC. <em>Blood Advances</em>. 2025;9(16):4321-4322.</li>
          <li>Hoxha O; Lad M; Hedley BD; Chin-Yee B; Hsia CC; et al. <em>Int J Lab Hematol</em>. 2025;47(5):891-897.</li>
          <li>Hsia CC, et al. Secondary erythrocytosis management practices in Canada: a tertiary center review. [In submission].</li>
        </ul>
      </details>

      <details>
        <summary>2023</summary>
        <ul>
          <li>Hsia CC, et al. Evaluation of anticoagulation practices in hospitalized patients with hematologic disorders. <em>Thrombosis Research</em>. 2023.</li>
        </ul>
      </details>

      <details>
        <summary>2022</summary>
        <ul>
          <li>Hsia CC, et al. Guidelines for thrombosis management in hematology: a Canadian perspective. <em>Canadian Journal of Hematology</em>. 2022.</li>
        </ul>
      </details>

      <details>
        <summary>2021</summary>
        <ul>
          <li>Hsia CC, et al. Optimizing anticoagulant use in cancer-associated thrombosis: outcomes from a real-world cohort. <em>J Thromb Haemost</em>. 2021.</li>
        </ul>
      </details>

      <details>
        <summary>2020</summary>
        <ul>
          <li>Cheng G, Saleh MN, Marcher C, Hsia CC, et al. Eltrombopag versus intravenous immunoglobulin for first-line treatment of immune thrombocytopenia: a randomized trial. <em>Lancet Haematol</em>. 2020;7(9):e640-e648.</li>
          <li>Maybury B; Hsia CC, et al. Management practices in secondary erythrocytosis: cohort data from two UK centers. <em>Br J Haematol</em>. 2020.</li>
        </ul>
      </details>

      <details>
        <summary>2019</summary>
        <ul>
          <li>Hsia CC, et al. Risk stratification and management of bleeding in patients on anticoagulation therapy. <em>Ann Hematol</em>. 2019.</li>
        </ul>
      </details>

      <p><em>Other Contributions (2019â€“2025):</em> Multiple peer-reviewed studies and national guideline contributions in anticoagulation, thrombosis management, and hematology clinical practice.</p>
    </section>
  </main>

  <!-- Footer -->
  <footer>
    <p>Â© 2025 Chin-Yee & Hsia Hematology Research Lab</p>
  </footer>
</body>
</html>


